Thyrocare Technologies Multibagger Stock 2020

Update: Peaked 50% from Recommended Price | Incredible | Subscribe Premium Service for Super Multibaggers & Real Investor Secrets

In this post we can explore Thyrocare Technologies as a Multibagger in Warren Buffet way in Indian Stock Market.

Thyrocare Technologies

BSE Code 539871
CMP 525.00
Free Report Yes
Publish Date May-9-2020

About Company

Thyrocare is India’s first fully automated diagnostic laboratory with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries.

Thyrocare operates with a Centralized Processing Laboratory (CPL) in Mumbai – India for esoteric tests; and Regional Processing Laboratory in major metro cities of India and other parts of Asia. We have focus on strong technologies, strong brands and strong systems that enable all laboratories to give their clients the best of science and technology at an affordable cost.


Warren Buffet, Value & Growth Checklist

Following are the Checklist parameters:

Capitalization 2700CR – Can provide good amount of growth to reach 100K Capitalization bce05 green e1587451073732
History of Consistently Increasing Sales, Earnings & Cash Flow Yes. bce05 green e1587451073732
Durable Competitive Advantage Moderate
Future Growth Drivers / Sector Growth Moderate
Conservative Debt (long term debt < 3 Net Profit) Low Debts bce05 green e1587451073732
Debt Equity Ratio, Current Ratio Low Debt

Current Ratio is 3

bce05 green e1587451073732
Return on Equity must be Above Average 20% bce05 green e1587451073732
Low CAPEX required to maintain current operations Moderate
Inventory Turnover Ratio, Debtor Days, ROCE Good bce05 green e1587451073732
Management is holding / buying the stock Promoter holding is at 66% & Increasing bce05 green e1587451073732
Market Price < Intrinsic Value Only at 10% Discount

Intrinsic Value Calculator

2d260 red
Stock Price is consolidating (now) Yes bce05 green e1587451073732
Stock Price is growing in past years along with EPS growth No, North-South curves exists bce05 green e1587451073732
Consolidated PE, PB Ratio, PEG Ratio PE 23 (High)

PB 8 (Very High)

PEG 1.6 (High)

2d260 red
Cash Flow Positive, Net Profit % greater than 8% Cash Flow: Okay

Profit %: 20%

bce05 green e1587451073732
Paying Dividends, Tax Yes DividendsYes Tax bce05 green e1587451073732
EPS Growth Rate 12% above past 2 years
Jump in Trailing Result EPS Yes
Jump in Quarterly Result EPS Yes bce05 green e1587451073732
Expected Gain in 5 Years 300-500% bce05 green e1587451073732
Price Movement Graph, 52 Week High & Low Okay
Volume Analysis 92 Thousand
Power of Brand Moderate
Corporate Governance, Reputation of Leaders Okay
Fraud reported No.

Positive Factors

Here are the positive factors regarding Thyrocare Technologies

  • Company is having Steady EPS Growth
  • Company have Low debts
  • Corona Issue is Accelerating Growth of Company

Concern Factors

Here are the concern factors regarding Thyrocare Technologies

  • Valuation is High due to PE & PB
  • Margin of Safety is Low – One has to Ensure Current Corona Impacts increases Sales


Based on the above analysis I would like to say that the Thyrocare Technologies possess Multibagger Stock properties and one can Invest in 2020.  However one should not expect high compounded returns from this stock.  It can be considered as Moderate Risk Moderate Returns investment.


FULL REPORT this is a free multibagger | BE our Premium Subscriber to get the Full Report of Multibaggers with Tracking & Updates. If you are a new investor & would like to gain stocks like Next Page Industries then join our 3Y Multibagger Subscription & Reap Ultimate profits of 10X in 10Years.  Don’t Wait – Subscribe!

Facebook Group | Ask  your Queries here


Update: 30% less in net profits results

Discussion on India Stock Market